Share Facebook Twitter LinkedIn Pinterest Email Shuttle Pharmaceuticals appoints Christopher Cooper as interim co-CEO
Co-Diagnostics anticipates India TB test commercialization by Q3 ’26 while exploring CoSara SPAC options (NASDAQ:CODX)April 1, 2026